Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

41.50
Delayed Data
As of May 22
 +0.65 / +1.59%
Today’s Change
30.89
Today|||52-Week Range
57.44
+15.73%
Year-to-Date

Today’s Trading

Previous close40.85
Today’s open41.51
Day’s range41.36 - 41.81
Volume4,196,310
Average volume (3 months)2,456,131
Market cap$78.3B
Dividend yield3.23%
Data as of 4:02pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.70%
Revenue growth (last year)+3.81%
P/E ratio2.7
Price/Sales5.48
Price/Book15.93

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.57+1.32%
AGNAllergan+0.39+0.18%
AZNAstraZeneca+0.05+0.15%
LLYEli Lilly and Co-0.82-1.05%
Data as of 4:02pm ET, 05/22/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.55
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts